Toenail Fungus: New Treatment Option

By Pacific Derm on October 4 2014

toenail fungusJUBLIA® (efinaconazole 10% topical solution) is a new treatment for toenail fungus. This prescription antifungal agent was approved by Health Canada in October 2013 for treatment of mild to moderate onychomycosis (nail fungus).

The solution is applied daily to the nail and comes in a bottle with a built-in flow-through brush applicator. JUBLIA® represents the first new drug treatment for this condition in over 10 years, increasing the number of therapeutic options for those experiencing this stubborn toenail fungal infection.

To review all your possible treatment options, make an appointment with your dermatologist.

 

 

Sources: Prevention Magazine and Jubliarx.com